UNSPSC 51343109: Ibacitabine

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C9H12IN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3EK8532DZV, chemically known as cytidine, 2-deoxy-5-iodo- (8ci)(9ci) but generally known as ibacitabine, which bears US NIH Compound Identifier 65050. European Medicines Agency schedules Ibacitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08090MIG. The term IBACITABINE is an International Non-Proprietary Name.

UNSPSC 51343109 Ibacitabine, a Commodity code, does not map to meaningful recent state and local procurement activity. The two opportunities tagged under this code — a pharmaceutical warehouse piggyback arrangement in Illinois for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida procurement for Naloxone and Drug Deactivation Systems — involve different active pharmaceutical ingredients and delivery mechanisms unrelated to ibacitabine, an antiviral compound. The code shows little relevant recent activity; the opportunities appear to be misclassified or the code is rarely used for the products state and local governments are actually sourcing in this pharmaceutical category.

Procurement professionals evaluating this code should treat it as inactive for practical business development purposes. No open solicitations under the code are currently posted, and the historical records do not support a discernible market for ibacitabine procurement at state and local levels. Vendors in this space should monitor related pharmaceutical commodity codes and work directly with state pharmacy benefit managers, department of health agencies, and county health procurement offices through cooperative purchasing vehicles such as MMCAP to access relevant opportunities in antivirals and specialty pharmaceuticals.